Tuesday, February 17, 2026
ADVT 
International

Trump says China panicked; markets slide deeper

Darpan News Desk IANS, 04 Apr, 2025 01:17 PM
  • Trump says China panicked; markets slide deeper

Washington, April 4 (IANS) US President Donald Trump on Friday said China had “panicked” by retaliating to his reciprocal tariff with a matching levy of 34 per cent on all imported goods from America.

Market turmoil deepened on news of China's retaliation. All major US indexes dropped more than 3 per cent in morning trading. And the tech-heavy Nasdaq Composite had fallen by 4 per cent, and the Wall Street Journal said, it was on pace to close in a bear market, meaning it has fallen more than 20 per cent from a recent peak.

Trump announced a 34 per cent tariff on imports from China on Wednesday, along with levies on all of America’s trading partner countries, including India with 26 per cent. A base-line rate of 10 per cent has been levied on all trading partner countries with some of them such as China, India, Japan, the EU and others, were hit with higher rates.

"China played it wrong, they panicked - the one thing they cannot afford to do!" the American President wrote on Truth Social, his social media platform.

The unsaid implication seemingly was that the president either expected or preferred that Beijing had chosen negotiation over retaliation.

“Well, it depends,” he said in response to a question from a reporter on Thursday if he was open to negotiations.

“If somebody said that we're going to give you something that's so phenomenal, as long as they're giving us something, that’s good.”

He said earlier: “The tariffs give us great power to negotiate. I've always used them very well in the first administration, as you saw, but now we're taking it to a whole new level, because it's a worldwide situation, and it's very exciting to see."

But his position seemed at odds with his top aides, who have said these tariffs are not negotiable.

“I don’t think there’s any chance…that President Trump’s going to back off his tariffs,” Howard Lutnick, secretary of commerce and a key architect of the president’s tariffs, said on Thursday. “The world should stop exploiting the United States of America.”

Top trade aide Peter Navarro told a media outlet the tariffs are “not a negotiation”.

MORE International ARTICLES

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK